Dasatinib and chronic myeloid leukaemia Patient Reports February 11, 2012

Dasatinib Side Effects Report #5087466-1
Dasatinib side effect was reported by a Health Professional from UNITED STATES on Jan 31, 2006. Male patient, 46 years of age, was diagnosed with leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia, graft versus host disease, hypoxia, infection , lower gastrointestinal haemorrhage. Dasatinib dosage: unknown. Patient was hospitalized. Patient recovered.

Dasatinib Side Effects Report #5107940-9
Dasatinib side effect was reported by a Health Professional from UNITED STATES on Jan 31, 2006. Male patient, 46 years of age, was diagnosed with leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia, graft versus host disease, hypoxia, infection , lower gastrointestinal haemorrhage. Dasatinib dosage: unknown. Patient was hospitalized. Patient recovered.

Dasatinib Side Effects Report #5121920-9
Dasatinib side effect was reported by a Health Professional from UNITED STATES on Jan 31, 2006. Male patient, 46 years of age, was diagnosed with leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: acute graft versus host disease in intestine, bacterial infection , blood culture positive, catheter related infection, chronic myeloid leukaemia, escherichia infection, fungal infection , gastritis, gastrointestinal oedema. Dasatinib dosage: unknown. Patient was hospitalized. Patient died on 03/01/2006.

Dasatinib Side Effects Report #5242687-X
Dasatinib side effect was reported by a Consumer or non-health professional from FINLAND on Feb 13, 2007. Male patient, 70 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cardiac failure, chronic myeloid leukaemia, dyspnoea, malignant neoplasm progression. Dasatinib dosage: 70MG FROM 24-NOV-05 - 23-DEC-05; 0MG FROM 24-DEC-05 - 26-JAN-06; 40 MG FROM 23-JUN-06-05-NOV-06. Patient was hospitalized. Patient died on 11/14/2006.


Dasatinib Side Effects Report #5270084-X
Dasatinib side effect was reported by a Consumer or non-health professional from FINLAND on Mar 20, 2007. Male patient, 70 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cardiac failure, chronic myeloid leukaemia, dyspnoea, malignant neoplasm progression. Dasatinib dosage: 70MG FROM 24-NOV-05 - 23-DEC-05; 0MG FROM 24-DEC-05 - 26-JAN-06; 40 MG FROM 23-JUN-06-05-NOV-06. Patient was hospitalized. Patient died on 11/14/2006.

Dasatinib Side Effects Report #5272835-7
Dasatinib side effect was reported by a Consumer or non-health professional from FINLAND on Mar 21, 2007. Male patient, 70 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cardiac failure, chronic myeloid leukaemia, dyspnoea, malignant neoplasm progression. Dasatinib dosage: 70MG FROM 24-NOV-05 - 23-DEC-05; 0MG FROM 24-DEC-05 - 26-JAN-06; 40 MG FROM 23-JUN-06-05-NOV-06. Patient was hospitalized. Patient died on 11/14/2006.

Dasatinib Side Effects Report #5164549-9
Dasatinib side effect was reported by a Consumer or non-health professional from FINLAND on Nov 28, 2006. Male patient, 70 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cardiac failure, chronic myeloid leukaemia, dyspnoea, malignant neoplasm progression. Dasatinib dosage: unknown. Patient was hospitalized. Patient died on 11/14/2006.

Dasatinib Side Effects Report #5087984-6
Dasatinib side effect was reported by a Health Professional from POLAND on Aug 14, 2006. Male patient, 44 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral ischaemia, chronic myeloid leukaemia, thrombocytopenia. Dasatinib dosage: 140MG 20DEC TO 14AUG06 180MG 15AUG TO 18AUG06. During the same period patient was treated with HUMULIN M. Patient was hospitalized. Patient died.

Dasatinib Side Effects Report #5092961-5
Dasatinib side effect was reported by a Health Professional from POLAND on Aug 14, 2006. Male patient, 44 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral ischaemia, chronic myeloid leukaemia, thrombocytopenia. Dasatinib dosage: 140MG 20DEC TO 14AUG06 180MG 15AUG TO 18AUG06. During the same period patient was treated with HUMULIN M. Patient was hospitalized. Patient died.


Dasatinib Side Effects Report #5095795-0
Dasatinib side effect was reported by a Health Professional from POLAND on Aug 14, 2006. Male patient, 44 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral ischaemia, chronic myeloid leukaemia, malignant neoplasm progression, thrombocytopenia. Dasatinib dosage: 140MG 20DEC TO 14AUG06 180MG 15AUG TO 18AUG06. During the same period patient was treated with HUMULIN M. Patient was hospitalized. Patient died.

Dasatinib Side Effects Report #5120736-7
Dasatinib side effect was reported by a Health Professional from POLAND on Aug 14, 2006. Male patient, 44 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, cerebral ischaemia, chronic myeloid leukaemia, thrombocytopenia. Dasatinib dosage: 140MG 20DEC TO 14AUG06 180MG 15AUG TO 18AUG06. During the same period patient was treated with HUMULIN M. Patient was hospitalized. Patient died on 08/18/2006.

Dasatinib Side Effects Report #5134145-8
Dasatinib side effect was reported by a Health Professional from POLAND on Aug 14, 2006. Male patient, 44 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: cerebral haemorrhage, chronic myeloid leukaemia, thrombocytopenia. Dasatinib dosage: 140MG 20DEC TO 14AUG06 180MG 15AUG TO 18AUG06. During the same period patient was treated with HUMULIN M. Patient was hospitalized. Patient died on 08/18/2006.

Dasatinib Side Effects Report #5053052-2
Dasatinib side effect was reported by a Health Professional from UNITED STATES on May 23, 2006. Male patient, 39 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia, dyspnoea, gastrointestinal ulcer, nausea , pleural effusion, respiratory failure, restrictive pulmonary disease. Dasatinib dosage: unknown. Patient was hospitalized. Patient died on 07/09/2006.

Dasatinib Side Effects Report #5063559-X
Dasatinib side effect was reported by a Health Professional from UNITED STATES on May 23, 2006. Male patient, 39 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia, duodenal ulcer, dyspnoea, gastrointestinal ulcer, malignant neoplasm progression, nausea , pleural effusion, respiratory distress, respiratory failure. Dasatinib dosage: unknown. Patient was hospitalized. Patient died on 07/09/2006.


Dasatinib Side Effects Report #5132558-1
Dasatinib side effect was reported by a Health Professional from UNITED STATES on May 23, 2006. Male patient, 39 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Dasatinib. After drug was administered, patient experienced the following side effects: chronic myeloid leukaemia, gastrointestinal ulcer, nausea , pleural effusion, respiratory failure, restrictive pulmonary disease. Dasatinib dosage: unknown. Patient was hospitalized. Patient died on 07/09/2006.